LABATE, ANGELO
 Distribuzione geografica
Continente #
NA - Nord America 6.242
AS - Asia 3.967
EU - Europa 1.827
SA - Sud America 898
AF - Africa 84
OC - Oceania 23
Continente sconosciuto - Info sul continente non disponibili 6
Totale 13.047
Nazione #
US - Stati Uniti d'America 6.034
SG - Singapore 1.863
CN - Cina 902
IT - Italia 737
BR - Brasile 684
VN - Vietnam 371
IN - India 367
SE - Svezia 237
GB - Regno Unito 211
HK - Hong Kong 172
DE - Germania 163
CA - Canada 145
AR - Argentina 91
EE - Estonia 91
BD - Bangladesh 71
FI - Finlandia 65
RU - Federazione Russa 65
ID - Indonesia 44
MX - Messico 42
ZA - Sudafrica 41
NL - Olanda 40
EC - Ecuador 38
IQ - Iraq 34
RO - Romania 33
FR - Francia 29
JP - Giappone 29
CO - Colombia 25
PL - Polonia 23
ES - Italia 22
UA - Ucraina 22
AU - Australia 20
CL - Cile 17
PK - Pakistan 16
TR - Turchia 16
PY - Paraguay 14
SA - Arabia Saudita 13
AT - Austria 12
MA - Marocco 11
VE - Venezuela 11
CH - Svizzera 10
PE - Perù 10
TN - Tunisia 10
UZ - Uzbekistan 10
EG - Egitto 9
GR - Grecia 9
CZ - Repubblica Ceca 8
IE - Irlanda 7
JM - Giamaica 7
AE - Emirati Arabi Uniti 6
IR - Iran 6
JO - Giordania 6
KR - Corea 6
KZ - Kazakistan 6
UY - Uruguay 6
BE - Belgio 5
A2 - ???statistics.table.value.countryCode.A2??? 4
DZ - Algeria 4
IL - Israele 4
KE - Kenya 4
NP - Nepal 4
PT - Portogallo 4
AZ - Azerbaigian 3
BG - Bulgaria 3
DO - Repubblica Dominicana 3
HU - Ungheria 3
LT - Lituania 3
MD - Moldavia 3
MK - Macedonia 3
MT - Malta 3
MY - Malesia 3
PH - Filippine 3
RS - Serbia 3
TT - Trinidad e Tobago 3
AL - Albania 2
BA - Bosnia-Erzegovina 2
BN - Brunei Darussalam 2
BO - Bolivia 2
CI - Costa d'Avorio 2
DK - Danimarca 2
EU - Europa 2
KW - Kuwait 2
LB - Libano 2
LU - Lussemburgo 2
NG - Nigeria 2
NI - Nicaragua 2
SI - Slovenia 2
AM - Armenia 1
BW - Botswana 1
CU - Cuba 1
GT - Guatemala 1
HN - Honduras 1
HR - Croazia 1
KG - Kirghizistan 1
LC - Santa Lucia 1
LK - Sri Lanka 1
LV - Lettonia 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
PA - Panama 1
PS - Palestinian Territory 1
Totale 13.042
Città #
San Jose 1.137
Chandler 660
Singapore 640
Dallas 630
Ashburn 550
Santa Clara 311
Bengaluru 278
Hefei 275
Milan 234
Princeton 220
Lawrence 219
Hong Kong 167
London 155
Chicago 148
Beijing 138
Ho Chi Minh City 128
Wilmington 118
Munich 109
Hanoi 94
Des Moines 79
Ottawa 75
Boardman 64
Los Angeles 63
São Paulo 63
New York 46
Turku 42
Catanzaro 40
Shanghai 38
Rome 37
Council Bluffs 26
The Dalles 26
Guangzhou 25
Rio de Janeiro 24
Helsinki 23
Naples 22
Orem 21
San Francisco 21
Da Nang 20
Johannesburg 20
Buffalo 19
Chennai 19
Redwood City 19
Warsaw 19
Columbus 18
Pune 18
Tokyo 18
Brooklyn 17
Mexico City 17
Amsterdam 16
Montreal 16
Norwalk 16
Redmond 16
Seattle 16
Belo Horizonte 15
Boston 14
Charlotte 14
Toronto 14
Atlanta 13
Brasília 13
Curitiba 13
Stockholm 13
Shenzhen 12
Guayaquil 11
Phoenix 11
Fortaleza 10
Jakarta 10
Ninh Bình 10
Quito 10
Tashkent 10
Augusta 9
Boydton 9
Campinas 9
Guarulhos 9
Melbourne 9
Miami 9
Timisoara 9
Baghdad 8
Biên Hòa 8
Catania 8
Dhaka 8
Falls Church 8
Haiphong 8
Horia 8
New Delhi 8
Santiago 8
St Petersburg 8
Thái Bình 8
Washington 8
Casalnuovo Di Napoli 7
Denver 7
Durban 7
Erbil 7
Florence 7
Frankfurt am Main 7
Istanbul 7
Lima 7
Mumbai 7
Paris 7
Piscataway 7
Porto Alegre 7
Totale 7.666
Nome #
Management of psychogenic non-epileptic seizures: a multidisciplinary approach 183
Genetics of reflex seizures and epilepsies in humans and animals 161
Predictive factors of Status Epilepticus and its recurrence in patients with adult–onset seizures: A multicenter, long follow–up cohort study 148
Levetiracetam vs Lamotrigine as First-Line Antiseizure Medication in Female Patients With Idiopathic Generalized Epilepsy 143
Rating Scale for Psychogenic Non-epileptic Seizures: Scale Development and Clinimetric Testing 129
A brainstem hypermetabolism in a patient with essential palatal tremor: A simultaneous 18F-FDG-PET/3 T-MRI study 104
Comparative Effectiveness of Brivaracetam, Cenobamate, Lacosamide, and Perampanel in Focal Epilepsy 102
A functional polymorphism in the SCN1A gene does not influence antiepileptic drug responsiveness in Italian patients with focal epilepsy 98
Temporal lobe abnormalities on brain MRI in healthy volunteers: a prospective case-control study 96
Adjunctive Brivaracetam in Focal Epilepsy: Real-World Evidence from the BRIVAracetam add-on First Italian netwoRk STudy (BRIVAFIRST) 95
3-T magnetic resonance imaging simultaneous automated multimodal approach improves detection of ambiguous visual hippocampal sclerosis. 94
Effectiveness of perampanel as only concomitant antiseizure medication for highly active epilepsy: insight from a real-world, multicenter retrospective study 93
A Functional Genetic Variation of the 5-HTR2A Receptor Affects Age at Onset in Patients with Temporal Lobe Epilepsy 90
Asymmetry of Permutation Entropy in Early Creutzfeldt-Jakob Disease: A Clue to a Specific Pathological Process? 84
Erratum: Sub-genic intolerance, ClinVar, and the epilepsies: A whole-exome sequencing study of 29,165 individuals (The American Journal of Human Genetics (2021) 108(6) (965–982), (S0002929721001403), (10.1016/j.ajhg.2021.04.009)) 84
Neocortical thinning in “benign” mesial temporal lobe epilepsy 81
A real-world comparison among third-generation antiseizure medications: Results from the COMPARE study 75
Age at onset predicts good seizure outcome in sporadic non-lesional and mesial temporal sclerosis based temporal lobe epilepsy 75
White matter abnormalities across different epilepsy syndromes in adults: an ENIGMA-Epilepsy study 74
A puzzling case without solution: isolated late-onset epileptic seizure 72
A Loss-of-Function HCN4 Mutation Associated With Familial Benign Myoclonic Epilepsy in Infancy Causes Increased Neuronal Excitability 72
Advanced morphological neuroimaging study in lateral temporal lobe epilepsy: A multicentric study 71
A new Italian instrument for the assessment of irritability in patients with epilepsy. 71
Network-based atrophy modeling in the common epilepsies: A worldwide ENIGMA study 71
A novel de novo HCN1 loss-of-function mutation in genetic generalized epilepsy causing increased neuronal excitability 71
Facemask headache: a new nosographic entity among healthcare providers in COVID-19 era 69
Adjunctive Brivaracetam in People with Epilepsy and Intellectual Disability: Evidence from the BRIVAracetam Add-On First Italian netwoRk Study 69
Hypertension, seizures, and epilepsy: a review on pathophysiology and management 68
Perampanel as first add-on choice on the treatment of mesial temporal lobe epilepsy: an observational real-life study 68
Long-term outcome of mild mesial temporal lobe epilepsy 67
A novel mutation in the Notch3 gene in an Italian family with cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy: genetic and magnetic resonance spectroscopic findings 66
Circulating microrna: The potential novel diagnostic biomarkers to predict drug resistance in temporal lobe epilepsy, a pilot study 66
Enlarging the clinical spectrum of chorea-acanthocytosis 65
Brivaracetam: review of its pharmacology and potential use as adjunctive therapy in patients with partial onset seizures 65
Recommendations for the use of structural magnetic resonance imaging in the care of patients with epilepsy: A consensus report from the International League Against Epilepsy Neuroimaging Task Force. 64
Antidepressant effect of vagal nerve stimulation in epilepsy patients: a systematic review 64
The Ketogenic Diet in Children with Epilepsy: A Focus on Parental Stress and Family Compliance 63
Exome sequencing of 20,979 individuals with epilepsy reveals shared and distinct ultra-rare genetic risk across disorder subtypes 63
Teaching NeuroImages: Pseudohypertrophic cerebral cortex in end-stage Creutzfeldt-Jakob disease 63
A possible case of natalizumab-dependent suicide attempt: A brief review about drugs and suicide. 63
Kufs disease due to mutation of CLN6: clinical, pathological and molecular genetic features. 63
Deep Learning Representation from Electroencephalography of Early-Stage Creutzfeldt-Jakob Disease and Features for Differentiation from Rapidly Progressive Dementia. 63
Effectiveness of perampanel as the only add‐on: Retrospective, multicenter, observational real‐life study on epilepsy patients 62
Epilepsy in cerebrovascular diseases: Review of experimental and clinical data with meta-analysis of risk factors 62
Deep learning representation from electroencephalography of early-stage creutzfeldt-jakob disease and features for differentiation from rapidly progressive dementia 62
Blocking out the real diagnosis 61
Topographic divergence of atypical cortical asymmetry and atrophy patterns in temporal lobe epilepsy 61
Adjunctive brivaracetam and sustained seizure frequency reduction in very active focal epilepsy 61
The mystery of unexplained traumatic sudden falls. A clinical case that adds a new feasible cause 60
Integrity of the corpus callosum in patients with benign temporal lobe epilepsy 60
The parkin gene is not involved in late-onset Parkinson’s disease 60
A familial t(4;8) translocation segregates with epilepsy and migraine with aura 60
Clinical utility of home videos for diagnosing epileptic seizures: a systematic review and practical recommendations for optimal and safe recording 60
Determinants of health-related quality of life in pharmacoresistant epilepsy: Results from a large multicenter study of consecutively enrolled patients using validated quantitative assessments 59
PCDH19 mutations in female patients from Southern Italy. 58
The ENIGMA-Epilepsy working group: Mapping disease from large data sets 58
Why should we change the term psychogenic nonepileptic seizures (PNES)? 57
AMPA receptors and perampanel behind selected epilepsies: current evidence and future perspectives 57
Effectiveness and safety of adjunctive cenobamate in people with focal-onset epilepsy: Interim results after 24-week observational period from the BLESS study 56
Brand-to-Generic Levetiracetam Switching: a four-years prospective observational real-life study 56
Identification of an Nav1.1 sodium channel (SCN1A) loss-of-function mutation associated with familial simple febrile seizures 56
Structural brain abnormalities in the common epilepsies assessed in a worldwide ENIGMA study 56
Profile of brivaracetam and its potential in the treatment of epilepsy 56
The impact of one-year COVID-19 containment measures in patients with mesial temporal lobe epilepsy: A longitudinal survey-based study 56
Polymorphism of the multidrug resistance 1 gene MDR1/ABCB1 C3435T and response to antiepileptic drug treatment in temporal lobe epilepsy 55
Value of multimodal imaging approach to diagnosis of neurosarcoidosis 55
Serum MicroRNAs as Predictors of Diagnosis and Drug-resistance in Temporal Lobe Epilepsy: A Preliminary Study 54
The broad-spectrum activity of perampanel: state of the art and future perspective of AMPA antagonism beyond epilepsy 54
Genome-wide association meta-analyses of drug-resistant epilepsy 54
A novel mutation in the notch3 gene in an Italian family with cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy: genetic and MRI spectroscopic analyses 54
Levetiracetam in patients with generalised epilepsy and myoclonic seizures: a open label study 54
Orbito-frontal thinning together with a somatoform dissociation might be the fingerprint of PNES 54
Homozygous c.649dupC mutation in PRRT2 worsens the BFIS/PKD phenotype with mental retardation, episodic ataxia, and absences 53
Acute bulbar palsy without ophtalmoplegia associated with anti-GD3 IgM antibodies. 53
Tacrolimus-induced polyneuropathy after heart transplantation 53
Psychopathological constellation in Psychogenic Non-Epileptic Seizures 53
Atlas of lesion locations and postsurgical seizure freedom in focal cortical dysplasia: A MELD study 53
May anti‐seizure medications alter brain structure in temporal lobe epilepsy? A prospective study 52
Brivaracetam as add-on treatment in patients with post-stroke epilepsy: real-world data from the BRIVAracetam add-on First Italian netwoRk Study (BRIVAFIRST) 52
Permutation entropy of scalp EEG: A tool to investigate epilepsies: Suggestions from absence epilepsies. 52
Hippocampal and thalamic atrophy in mild temporal lobe epilepsy: a VBM study 52
Advanced MRI Morphologic Study Shows No Atrophy in Healthy Individuals with Hippocampal Hyperintensity 52
Psychiatric Assessment in Patients with Mild Temporal Lobe Epilepsy 52
Structural brain abnormalities in the common epilepsies assessed in 3,876 individuals worldwide 52
GABA(B) receptor 1 polymorphism (G1465A) is associated with temporal lobe epilepsy 52
Anti-GM1 antibodies are not associated with cerebral atrophy in patients with multiple sclerosis 52
Epilepsy subtype-specific copy number burden observed in a genome-wide study of 17458 subjects 52
Usefulness of a morning routine EEG recording in patients with juvenile myoclonic epilepsy. 51
Neuropsychological profile of mild temporal lobe epilepsy 51
Gerstmann-Straussler-Scheinker disease with PRNP P102L heterozygous mutation presenting as progressive myoclonus epilepsy. 51
Non-paraneoplastic limbic encephalitis characterized by mesio-temporal seizures and extratemporal lesions: a case report 51
Temporal lobe epilepsy as a unique manifestation of multiple sclerosis 51
No evidence of a role for cystatin B gene in juvenile myoclonic epilepsy. 51
Chronic neuroborreliosis by B. garinii: an unusual case presenting with epilepsy and multifocal brain MRI lesions 51
Corrigendum to “Advanced morphological neuroimaging study in lateral temporal lobe epilepsy: A multicentric study” [Epilepsy Behav 74 (2017) Pages 69–72] 51
Midbrain meningioma causing subacute parkinsonism 51
Diagnostic and therapeutic approach to drug-resistant juvenile myoclonic epilepsy 51
Artificial intelligence for classification of temporal lobe epilepsy with ROI-level MRI data: A worldwide ENIGMA-Epilepsy study 51
Predictors of Seizure Recurrence in Women With Idiopathic Generalized Epilepsy Who Switch From Valproate to Another Medication 51
Utility and limitations of homemade videos in differentiating functional seizures from other paroxysmal events: An Italian cohort study 50
Totale 6.721
Categoria #
all - tutte 125.665
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 125.665


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022666 14 1 0 173 66 13 13 133 81 63 104 5
2022/20231.784 446 94 44 202 207 175 4 110 271 102 107 22
2023/2024828 167 119 83 51 56 189 16 30 9 17 26 65
2024/20253.104 365 216 168 146 212 409 127 94 352 222 267 526
2025/20266.452 332 663 895 1.069 594 226 815 358 778 423 191 108
2026/202752 52 0 0 0 0 0 0 0 0 0 0 0
Totale 13.298